EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds



Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds



Official Gazette of the United States Patent & Trademark Office Patents 1257(5), Apr 30



The present invention is directed to a method for treating dermal atrophy of the skin. The method of the invention includes applying a composition to the skin of a mammal suffering from dermal atrophy of the skin, and comprising at least one thyroid hormone compound or thyroid hormone-like compound together with a pharmacologically acceptable base suitable for topical application, wherein the thyroid hormone compound or the thyroid hormone-like compound binds to TR-alpha or TR-beta with an equilibrium dissociation constant, Kd, of at least 10-5 M. The invention is also directed to an article of manufacture comprising packaging material and a pharmaceutical agent contained within the packaging material, wherein the pharmaceutical agent is therapeutically effective for treating dermal atrophy of the skin.

(PDF 0-2 workdays service: $29.90)

Accession: 035980197

Download citation: RISBibTeXText



Related references

Thyroid hormone receptor isoform selectivity of thyroid hormone disrupting compounds quantified with an in vitro reporter gene assay. Environmental Toxicology and Pharmacology 23(3): 302-307, 2007

Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney. Toxicology 205(1-2): 95-102, 2004

Mechanistic analysis of metabolomics patterns in rat plasma during administration of direct thyroid hormone synthesis inhibitors or compounds increasing thyroid hormone clearance. Toxicology Letters 225(2): 240-251, 2014

Endocrine disease: progress in diagnosis and treatment. Topics: II. Progress in treatment: 4. Thyroid hormone and lipid metabolism: novel thyroid hormone receptor beta1 selective thyroid hormone analogs. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 101(4): 1000-1006, 2012

Thyroid stimulating hormone receptor studies rationale for treatment of patients with multinodular goiter and differentiated thyroid tumors with thyroid hormone. Roeher, H -D And O H Clark (Ed ) Progress in Surgery, Vol 19 Thyroid Tumors Vii+227p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 181-204, 1988

Effect of surgical treatment on prolactin and thyroid stimulating hormone responsiveness to thyroid releasing hormone in patients with autonomous thyroid nodules. Acta Endocrinologica Supplementum (225): 38, 1979

Thyroid hormones and thyroid stimulating hormone prolactin and luteinizing hormone responses to repeated thyroid hormone releasing hormone and luteinizing hormone releasing hormone injections in depressed patients. Acta Psychiatrica Scandinavica 59(5): 536-544, 1979

Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease. Journal of Oncology 2016: 6496750-6496750, 2016

Receptors for thyrotropin-releasing hormone, thyroid-stimulating hormone, and thyroid hormones in the macaque uterus: effects of long-term sex hormone treatment. Menopause 19(11): 1253-1259, 2013

Severe thyroid atrophy due to prolonged ingestion of thyroid hormone for treatment of obesity. Southern Medical Journal 77(2): 268-270, 1984

Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone receptor beta gene (P453T). Journal of Laboratory and Clinical Medicine 146(2): 85-94, 2005

Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone. Molecular Endocrinology 17(9): 1767-1776, 2003

Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone beta receptor gene (P453T). Journal of Laboratory and Clinical Medicine 146(2): 85-94, 2005

Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer. Nuclear Medicine and Molecular Imaging 49(2): 115-121, 2015

Dna and thyroid hormone binding properties of a mutant thyroid hormone receptor c erba beta responsible for generalized thyroid hormone resistance gthr. Clinical Research 38(2): 474A, 1990